Johnson & Johnson (JNJ) Tops Q2 EPS by 5c; Reaffirms Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mail
Get Alerts JNJ Hot Sheet
Price: $263.81 -1.42%
Financial Fact:
Selling, marketing and administrative expenses: 4.77B
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Financial Fact:
Selling, marketing and administrative expenses: 4.77B
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Johnson & Johnson (NYSE: JNJ) reported Q2 EPS of $1.28, $0.05 better than the analyst estimate of $1.23. Revenue for the quarter came in at $16.6 billion versus the consensus estimate of $16.22 billion.
Reaffirms outlook.
Reaffirms outlook.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Erste Group Downgrades Johnson & Johnson (JNJ) to Hold
- American Express Q3 earnings preview: stronger print expected on resilient spending
- World Acceptance (WRLD) Tops Q2 EPS by 113c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot ListSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
